date:Dec 29, 2012
cal solutions for human heath. Since 2010, the company has been listed on the Spanish Alternative Investment Market (MAB).
In December 2011, AB-BIOTICS closed a fundraising round of EUR4.3 million to tackle the 1st phase of the companys internationalization plan. The goal is to have presence in markets such as Brazil, USA, Mexico, UK, Germany, France and Turkey, especially to market its personalized medicine solutions and licensing its line of functional ingredients, including AB-Fortis.
The